51,743 results on '"rectal neoplasms"'
Search Results
2. Mastering rectal cancer MRI: From foundational concepts to optimal staging
3. Clinical evaluation of accelerated diffusion-weighted imaging of rectal cancer using a denoising neural network
4. Assessing the role of prognostic nutritional index in predicting outcomes for rectal cancer surgery
5. Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial (ID-COMET)
6. Natural Killer (NK) Cells in Combination with Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
7. Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) (COLORE)
8. Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)
9. Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer
10. Abdominopelvic Cancer Prehabilitation
11. Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
12. Effect of Time-Restricted Eating During Cancer Treatment in Alaska Native Patients with Rectal Cancer
13. Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer (NORAD01)
14. Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
15. SCRT(Short Course Radiotherapy) Combined With CAPOX Plus QL1706 for Rectal Cancer Liver Metastases
16. Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
17. Radiation-induced Diarrhoea During Curative EBRT of Prostate and Rectal Cancer (PRECANU)
18. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
19. Project HERO: Health Empowerment & Recovery Outcomes (HERO)
20. Study on the Applicability of CCR Criteria in Rectal Cancer
21. Transanal Irrigation for Low Anterior Resection Syndrome (TraLARS)
22. Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
23. Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
24. Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer (R-IMMUNE)
25. Supportive Oncology Care At Home RCT
26. SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer(SPARKLE)
27. Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer (BASKET)
28. SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer (SMART TNT)
29. Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer
30. Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail (PICS)
31. Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer (TORCH)
32. SCRT in TNT With or Without Chlorophyllin (SCOTCH)
33. SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial
34. CLASSICA: Validating AI in Classifying Cancer in Real-Time Surgery
35. Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
36. Exercise for Improving Long-course Chemoradiotherapy Efficacy in People with Locally Advanced Rectal Cancer
37. Exercise for Improving Radiotherapy Efficacy in Rectal Cancer
38. Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer
39. FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery
40. The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal Cancer (TORCH-E)
41. Feasibility Study of a Molecular Karyotype Using a Very High-throughput Sequencing Approach, the 'Massive Parallel Sequencing' on Circulating Tumor DNA
42. S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
43. A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
44. Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT) (PUCRT)
45. Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer
46. Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation (JANUS)
47. Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer (mRCAT-III)
48. Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
49. Implementation of a Tumor Response Assessment Program Integrating the Shared Medical Decision Into the Organ Preservation Strategy for Rectal Cancer Patients (EVAREC)
50. Nodes-sparing Short-course Radiation Combined With CAPOX and Tislelizumab for MSS Middle and Low Rectal Cancer (mRCAT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.